tiprankstipranks
Exosens (EXOSF)
OTHER OTC:EXOSF
US Market

Exosens (EXOSF) Ratios

0 Followers

Exosens Ratios

EXOSF's free cash flow for Q2 2026 was €0.13. For the 2026 fiscal year, EXOSF's free cash flow was decreased by € and operating cash flow was €0.12. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
2.35 2.46 2.94 1.75 2.00
Quick Ratio
1.40 1.54 2.07 1.04 1.23
Cash Ratio
0.53 0.60 1.10 0.14 0.40
Solvency Ratio
0.30 0.19 0.17 0.11 0.09
Operating Cash Flow Ratio
0.91 0.87 0.90 0.46 0.66
Short-Term Operating Cash Flow Coverage
393.52 28.76 37.14 9.24 6.53
Net Current Asset Value
€ -138.50M€ -153.10M€ -90.20M€ -259.64M€ -201.46M
Leverage Ratios
Debt-to-Assets Ratio
0.30 0.32 0.32 0.47 0.48
Debt-to-Equity Ratio
0.60 0.63 0.63 1.53 1.39
Debt-to-Capital Ratio
0.37 0.39 0.39 0.60 0.58
Long-Term Debt-to-Capital Ratio
0.36 0.37 0.38 0.59 0.57
Financial Leverage Ratio
1.98 1.97 1.98 3.22 2.89
Debt Service Coverage Ratio
12.12 7.20 3.42 2.27 2.02
Interest Coverage Ratio
7.66 7.41 2.76 1.80 2.01
Debt to Market Cap
0.09 0.11 0.25 0.50 0.40
Interest Debt Per Share
5.52 5.77 5.69 11.27 8.90
Net Debt to EBITDA
1.24 1.49 1.25 3.53 4.42
Profitability Margins
Gross Profit Margin
17.43%21.83%57.24%55.46%56.76%
EBIT Margin
17.39%21.83%19.54%15.60%16.07%
EBITDA Margin
32.65%30.35%29.23%26.32%25.53%
Operating Profit Margin
17.96%21.83%19.51%17.34%15.17%
Pretax Profit Margin
15.10%18.84%10.61%5.94%8.52%
Net Profit Margin
11.59%9.12%7.79%5.38%5.59%
Continuous Operations Profit Margin
11.59%14.99%7.79%5.77%5.59%
Net Income Per EBT
76.78%48.41%73.44%90.51%65.55%
EBT Per EBIT
84.05%86.30%54.36%34.26%56.17%
Return on Assets (ROA)
6.43%4.86%3.76%2.61%2.12%
Return on Equity (ROE)
12.85%9.58%7.44%8.40%6.13%
Return on Capital Employed (ROCE)
11.67%13.36%10.83%10.12%6.67%
Return on Invested Capital (ROIC)
8.90%10.54%7.90%9.03%4.28%
Return on Tangible Assets
12.40%10.17%7.26%5.03%5.38%
Earnings Yield
2.06%1.73%3.11%2.82%1.84%
Efficiency Ratios
Receivables Turnover
6.50 6.40 5.55 4.61 6.14
Payables Turnover
11.52 11.73 6.48 4.40 3.79
Inventory Turnover
3.33 3.48 1.81 1.81 1.56
Fixed Asset Turnover
3.44 3.65 3.78 3.85 3.32
Asset Turnover
0.56 0.53 0.48 0.49 0.38
Working Capital Turnover Ratio
2.90 2.51 2.72 4.12 3.05
Cash Conversion Cycle
134.17 130.69 210.89 198.08 197.22
Days of Sales Outstanding
56.13 56.99 65.76 79.22 59.42
Days of Inventory Outstanding
109.71 104.81 201.45 201.91 234.06
Days of Payables Outstanding
31.68 31.11 56.32 83.04 96.26
Operating Cycle
165.84 161.80 267.21 281.13 293.48
Cash Flow Ratios
Operating Cash Flow Per Share
2.32 1.94 1.89 1.66 1.56
Free Cash Flow Per Share
1.11 0.95 1.89 0.64 0.85
CapEx Per Share
1.21 0.98 0.81 1.02 0.72
Free Cash Flow to Operating Cash Flow
0.48 0.49 1.00 0.39 0.54
Dividend Paid and CapEx Coverage Ratio
1.54 1.79 2.33 1.63 2.18
Capital Expenditure Coverage Ratio
1.92 1.97 2.33 1.63 2.18
Operating Cash Flow Coverage Ratio
0.44 0.35 0.37 0.16 0.19
Operating Cash Flow to Sales Ratio
0.24 0.21 0.24 0.16 0.24
Free Cash Flow Yield
2.02%1.97%9.75%3.21%4.23%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
92.97 57.68 32.38 35.46 54.21
Price-to-Sales (P/S) Ratio
5.62 5.27 2.50 1.91 3.03
Price-to-Book (P/B) Ratio
6.20 5.54 2.39 2.98 3.32
Price-to-Free Cash Flow (P/FCF) Ratio
49.41 50.88 10.26 31.13 23.66
Price-to-Operating Cash Flow Ratio
23.66 25.03 10.26 12.04 12.80
Price-to-Earnings Growth (PEG) Ratio
-1.83 1.44 4.53 0.69 -0.50
Price-to-Fair Value
6.20 5.54 2.39 2.98 3.32
Enterprise Value Multiple
18.45 18.85 9.82 10.77 16.28
Enterprise Value
2.99B 2.68B 1.13B 904.06M 834.07M
EV to EBITDA
18.45 18.85 9.82 10.77 16.28
EV to Sales
6.03 5.72 2.87 2.84 4.15
EV to Free Cash Flow
52.96 55.24 11.75 46.30 32.47
EV to Operating Cash Flow
25.35 27.17 11.75 17.91 17.57
Tangible Book Value Per Share
0.39 -0.27 0.36 -3.68 -4.53
Shareholders’ Equity Per Share
8.85 8.75 8.12 6.72 6.02
Tax and Other Ratios
Effective Tax Rate
0.23 0.20 0.27 0.09 0.34
Revenue Per Share
9.75 9.19 7.76 10.49 6.61
Net Income Per Share
1.13 0.84 0.60 0.56 0.37
Tax Burden
0.77 0.48 0.73 0.91 0.66
Interest Burden
0.87 0.86 0.54 0.38 0.53
Research & Development to Revenue
0.00 0.00 0.00 0.03 0.02
SG&A to Revenue
0.04 0.00 0.29 0.26 0.31
Stock-Based Compensation to Revenue
0.00 0.00 0.00 0.00 <0.01
Income Quality
2.05 1.40 3.13 2.74 4.24
Currency in EUR